BOLT

3.58

0.28% -0.010

Dopo l'orario di chiusura: 3.58

Bolt Biotherapeutics Inc (BOLT)

Panoramica Notizia Cronologia dei prezzi Financials Forum Previsione

Precedente Chiudi:

$3.59

Aprire:

$3.6

Volume 24 ore:

4,100

Relative Volume:

0.16

Capitalizzazione di mercato:

$6.90M

Reddito:

$6.50M

Utile/perdita netta:

$-29.58M

Rapporto P/E:

-0.2191

EPS:

-16.3362

Flusso di cassa netto:

$-34.58M

1 W Prestazione:

+0.56%

1M Prestazione:

-7.01%

6M Prestazione:

-20.44%

1 anno Prestazione:

-35.27%

Intervallo 1D:

$3.58

$3.68

Intervallo di 1 settimana:

$3.38

$3.90

Portata 52W:

$3.10

$7.1999

Bolt Biotherapeutics Inc Stock (BOLT) Company Profile

Nome

Bolt Biotherapeutics Inc

Settore

Healthcare (1067)

Industria

Biotechnology (595)

Telefono

650-665-9295

Indirizzo

900 CHESAPEAKE DRIVE, REDWOOD CITY

Dipendente

Cinguettio

Prossima data di guadagno

2026-11-11

Ultimi documenti SEC

BOLT's Discussions on Twitter

Compare BOLT vs VRTX, REGN, MRNA, ARGX, RVMD

Azioni	Prezzo	Cap. di mercato	Reddito	Reddito netto	Flusso di cassa	EPS
BOLT Bolt Biotherapeutics Inc	3.58	6.90M	6.50M	-29.58M	-34.58M	-16.34
VRTX Vertex Pharmaceuticals Inc	526.19	133.37B	12.34B	4.34B	3.71B	16.87
REGN Regeneron Pharmaceuticals Inc	788.04	81.13B	14.92B	4.42B	3.79B	41.04
MRNA Moderna Inc	198.88	79.40B	2.23B	-3.19B	-1.60B	-8.1462
ARGX Argen X Se Adr	959.49	60.03B	4.16B	1.29B	734.26M	19.58
RVMD Revolution Medicines Inc	204.97	43.93B	742.00K	-1.37B	-1.07B	-7.0731

Bolt Biotherapeutics Inc Stock (BOLT) Upgrades & Downgrades

Data	Azione	Analista	Modifica della valutazione
2025-10-20	Ripresa	H.C. Wainwright	Buy
2022-01-06	Downgrade	Morgan Stanley	Overweight → Equal-Weight
2021-03-02	Iniziato	Guggenheim	Buy
2021-03-02	Iniziato	Morgan Stanley	Overweight
2021-03-02	Iniziato	SVB Leerink	Outperform
2021-03-02	Iniziato	Stifel	Buy

Mostra tutto

Bolt Biotherapeutics Inc Borsa (BOLT) Ultime notizie

Sep 22, 2026

Bolt Biotherapeutics CEO Quinn sells $58,402 in stock By Investing.com - Investing.com South Africa

Sep 22, 2026

Sep 21, 2026

Bolt Biotherapeutics CEO Quinn sells $58,402 in stock - Investing.com

Sep 21, 2026

Bolt Biotherapeutics COO Grant Yonehiro sells $43,806 in company shares By Investing.com - Investing.com Nigeria

Sep 21, 2026

Bolt Biotherapeutics senior VP Nemec sells $26,072 in shares By Investing.com - Investing.com Canada

Sep 21, 2026

Bolt Biotherapeutics COO Grant Yonehiro sells $43,806 in company shares - Investing.com

Sep 21, 2026

Bolt Biotherapeutics (BOLT) CEO logs stock sales and an ESPP buy - Stock Titan

Sep 21, 2026

Sep 20, 2026

Bolt Biotherapeutics (BOLT) Climbs 6.43% to $3.56 as Shares Test Upper RangeMcClellan Oscillator - careplusvn.com

Sep 20, 2026

Sep 11, 2026

BOLT - Finviz

Sep 11, 2026

Sep 03, 2026

BOLT Q2 2026 Earnings: Wider-than-Expected Per-Share Loss of -$4.57 Highlights Cost PressuresEBITDA Margin Trends - vinanet.vn

Sep 03, 2026

Aug 31, 2026

Bolt Biotherapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update - Barchart.com

Aug 31, 2026

BOLT Q2 2026 Earnings: Widened Loss of -$4.57 Per Share Misses Consensus by 32.3%Return On Assets - vinanet.vn

Aug 31, 2026

Aug 28, 2026

Bolt Biotherapeutics . Stock Price Forecast. Should You Buy BOLT? - StockInvest.us

Aug 28, 2026

Bolt Biotherapeutics (BOLT) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Aug 28, 2026

Aug 24, 2026

Bolt (BOLT) Snapshot: Finishes 2.05% Higher at $3.74 for the Current Session; Next Test: the Supplied Trading Band Runs From $3.55 to $3.93 under the Current SnapshotDividend Growth Stocks - siam.in

Aug 24, 2026

Aug 19, 2026

Bolt (BOLT) Levels: Records a 2.60% Increase to $3.26 in the Current Update; Price Context: the Near-Term Reference Band Stretches From $3.10 to $3.42 in the Current UpdateTrend Following Picks - vinanet.vn

Aug 19, 2026

Price Context: the Near-Term Reference Band Stretches From $3.10 to $3.42 in the Current UpdateRunaway Gap - dars.gov.et

Aug 19, 2026

Aug 18, 2026

Bolt (BOLT) Quarterly Figures: The EPS Result Is Below Expectation; Price Reaction: Shares Fall 0.72%Buyback Announcement Report - vinanet.vn

Aug 18, 2026

Aug 14, 2026

Bolt Biotherapeutics (BOLT) Gains 4.36% as Shares Test Key Technical LevelsLarge Cap Trends - Vinanet

Aug 14, 2026

Aug 13, 2026

Renaissance Technologies (BOLT) reports 5.13% ownership stake in Bolt Biotherapeutics - Stock Titan

Aug 13, 2026

Aug 12, 2026

Bolt Biotherapeutics Reports Second Quarter 2026 Financial Results and Provides Business Update - The Manila Times

Aug 12, 2026

Aug 11, 2026